• COVID-19
  • Vulvovaginal Disease
  • Uterine Fibroids
  • Cervical Health
  • Endometriosis
  • Legally Speaking
  • Mental Health
  • Drug Pipeline News
  • Well Woman
  • Sexually Transmitted Infections
  • Genetic Testing
  • Imaging
  • Infertility
  • Malpractice
  • Menopause
  • Osteoporosis
  • Pregnancy and Birth
  • Gynecology
  • Obstetrics
  • Pediatrics
  • Surgery
  • Urology
  • Dermatology
  • Breast Health
  • Practice Management
  • Technology
  • Noninvasive Prenatal Testing
  • Curbside Consults
  • Life Transitions
  • Opinion
  • LARC
  • Contraception
  • Sexual Health

Latest News

FDA updates warning for liver injury due to fezolinetant
FDA updates warning for liver injury due to fezolinetant

September 13th 2024

The FDA upped the recommended rate of liver blood tests for patients initiating fezolinetant on the basis of a post-marketing case report involving serious liver injury.

Image credit: © highwaystarz - stock.Adobe.com
Investigational nasal spray shows promise vasomotor symptom treatment

September 13th 2024

SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances | Image Credit: © stokkete - © Jstokkete - stock.adobe.com.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances

September 13th 2024

Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Elinzanetant displays positive phase 3 safety and efficacy data against VMS

September 13th 2024

The Menopause Society reports low rates of hormone therapy usage | Image Credit: © Vitalii Vodolazskyi - © Vitalii Vodolazskyi - stock.adobe.com.
The Menopause Society reports low rates of hormone therapy usage

September 13th 2024

Conference Coverage

View All
Image credit: © highwaystarz - stock.Adobe.com
Investigational nasal spray shows promise vasomotor symptom treatment

September 13th 2024

SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances | Image Credit: © stokkete - © Jstokkete - stock.adobe.com.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances

September 13th 2024

The Menopause Society reports low rates of hormone therapy usage | Image Credit: © Vitalii Vodolazskyi - © Vitalii Vodolazskyi - stock.adobe.com.
The Menopause Society reports low rates of hormone therapy usage

September 13th 2024

Image credit: © highwaystarz - stock.adobe.com.
Study shows hormone therapy offers lasting benefits for women over 65

September 12th 2024

Video Series
Video Interviews

All News

© 2024 MJH Life Sciences

All rights reserved.